Buprenorphine Tablet
Product Images NDC 71335-3152

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 71335-3152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine-figure (Buprenorphine Figure)

Illustration showing placement of a sublingual tablet under the tongue, demonstrating the administration route for buprenorphine sublingual tablets.*

FDA Label Image

Buprenorphine-str (Buprenorphine Str)

Chemical structure of Buprenorphine hydrochloride, depicting its molecular arrangement with rings, functional groups including hydroxyl and methoxy, and a cyclopropylmethyl substituent.*

FDA Label Image

Label (Lbl713353152)

Label for Buprenorphine Sublingual Tablets, 8 mg strength, repackaged by Bryant Ranch Prepack and manufactured by Sun Pharmaceutical Industries Ltd. The label states the package contains 90 tablets and includes storage instructions (20° to 25°C) and pharmacist dispensing guidance. The label features a barcode, QR codes, and various safety warnings including emergency care instructions for accidental ingestion by children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.